GLPG Quote, Financials, Valuation and Earnings

Celyad Oncology SA has a net margin of -286.67% compared to Galapagos NV's net margin of --. Galapagos NV's return on equity of -16.48% beat Celyad Oncology SA's return on equity of --.

Galapagos NV has a consensus price target of $27.34, signalling downside risk potential of -18.17%. On the other hand Celyad Oncology SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Galapagos NV has higher upside potential than Celyad Oncology SA, analysts believe Galapagos NV is more attractive than Celyad Oncology SA.

Galapagos NV has a beta of 0.236, which suggesting that the stock is 76.408% less volatile than S&P 500. In comparison Celyad Oncology SA has a beta of 0.181, suggesting its less volatile than the S&P 500 by 81.876%.

Galapagos NV has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Celyad Oncology SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Galapagos NV pays -- of its earnings as a dividend. Celyad Oncology SA pays out -- of its earnings as a dividend.

Galapagos NV quarterly revenues are $83.2M, which are larger than Celyad Oncology SA quarterly revenues of --. Galapagos NV's net income of -$238.4M is higher than Celyad Oncology SA's net income of --. Notably, Galapagos NV's price-to-earnings ratio is 21.30x while Celyad Oncology SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Galapagos NV is 7.03x versus 30.84x for Celyad Oncology SA. Usually stocks with elevated PS ratios are considered overvalued.

Ion Beam Applications SA has a net margin of -286.67% compared to Galapagos NV's net margin of --. Galapagos NV's return on equity of -16.48% beat Ion Beam Applications SA's return on equity of 8.22%.

Galapagos NV has a consensus price target of $27.34, signalling downside risk potential of -18.17%. On the other hand Ion Beam Applications SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Galapagos NV has higher upside potential than Ion Beam Applications SA, analysts believe Galapagos NV is more attractive than Ion Beam Applications SA.

Galapagos NV has a beta of 0.236, which suggesting that the stock is 76.408% less volatile than S&P 500. In comparison Ion Beam Applications SA has a beta of 1.153, suggesting its more volatile than the S&P 500 by 15.339%.

Galapagos NV has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ion Beam Applications SA offers a yield of 1.52% to investors and pays a quarterly dividend of $0.28 per share. Galapagos NV pays -- of its earnings as a dividend. Ion Beam Applications SA pays out 53.12% of its earnings as a dividend. Ion Beam Applications SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Galapagos NV quarterly revenues are $83.2M, which are larger than Ion Beam Applications SA quarterly revenues of --. Galapagos NV's net income of -$238.4M is higher than Ion Beam Applications SA's net income of --. Notably, Galapagos NV's price-to-earnings ratio is 21.30x while Ion Beam Applications SA's PE ratio is 24.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Galapagos NV is 7.03x versus 0.82x for Ion Beam Applications SA. Usually stocks with elevated PS ratios are considered overvalued.

UCB SA has a net margin of -286.67% compared to Galapagos NV's net margin of --. Galapagos NV's return on equity of -16.48% beat UCB SA's return on equity of 13.88%.

Galapagos NV has a consensus price target of $27.34, signalling downside risk potential of -18.17%. On the other hand UCB SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Galapagos NV has higher upside potential than UCB SA, analysts believe Galapagos NV is more attractive than UCB SA.

Galapagos NV has a beta of 0.236, which suggesting that the stock is 76.408% less volatile than S&P 500. In comparison UCB SA has a beta of 0.678, suggesting its less volatile than the S&P 500 by 32.194%.

Galapagos NV has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UCB SA offers a yield of 0.49% to investors and pays a quarterly dividend of $0.79 per share. Galapagos NV pays -- of its earnings as a dividend. UCB SA pays out 15.96% of its earnings as a dividend. UCB SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Galapagos NV quarterly revenues are $83.2M, which are larger than UCB SA quarterly revenues of --. Galapagos NV's net income of -$238.4M is higher than UCB SA's net income of --. Notably, Galapagos NV's price-to-earnings ratio is 21.30x while UCB SA's PE ratio is 37.32x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Galapagos NV is 7.03x versus 8.52x for UCB SA. Usually stocks with elevated PS ratios are considered overvalued.